4:10 PM ET
8-K
Divestiture
Inogen Divestiture to Rotech Healthcare Inc. for $24.8M
Inogen agreed to sell substantially all assets of its U.S. oxygen rental business to Rotech Healthcare for an estimated $24.8 million. The divestiture is intended to streamline Inogen's commercial model and shift focus toward its product supply business, supported by a new long-term supply agreement with Rotech. Upon closing, Inogen will also increase its share repurchase authorization from $30 million to $45 million.
- Value
- $24.8M
- Counterparty
- Rotech Healthcare Inc.